参考文献/References:
[1]吕桂帅,陈磊,王红阳.我国肝癌研究的现状与前景[J].生命科学,2015,27(3):237-248.[2]Kogure T,Lin WL,Yan IK,et al.Intercellular nanovesicle-mediated microRNA transfer:a mechanism of environmental modulation of hepatocellular cancer cell growth[J].Hepatology,2011,54(4):1237-1248.[3]Yu S,Cao H,Shen B,et al.Tumor-derived exosomes in cancer progression and treatment failure[J].Oncotarget,2015,6(35):37151-37168.[4]Azmi AS,Bao B,Sarkar FH.Exosomes in cancer development, metastasis, and drug resistance:a comprehensive review[J].Cancer and Metastasis Reviews,2013,32(3-4):623-642.[5]Li L,Tang J,Zhang B,et al.Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4[J].Gut,2015,64(1):156-167.[6]Santhekadur PK,Das SK,Gredler R,et al.Multifunction Protein Staphylococcal Nuclease Domain Containing 1 (SND1) Promotes Tumor Angiogenesis in Human Hepatocellular Carcinoma through Novel Pathway That Involves Nuclear Factor κB and miR-221[J].Journal of Biological Chemistry,2012,287(17):13952-13958.[7]Zhang N,Duan WD,Leng JJ,et al.STAT3 regulates the migration and invasion of a stemlike subpopulation through microRNA21 and multiple targets in hepatocellular carcinoma[J].Oncology Reports,2015,33(3):1493-1498.[8]Yilmaz M,Christofori G.EMT, the cytoskeleton, and cancer cell invasion[J].Cancer and Metastasis Reviews,2009,28(1-2):15-33.[9]Bruix J,Llovet JM.Major achievements in hepatocellular carcinoma[J].Lancet,2009,373(9664):614-616.[10]Brissot E,Myriam L,Marielle MB,et al.Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia[J].Haematologica,2015,100(3):392-399.[11]张云,庹敏,刘胜武.血清外泌体来源的miRNA-122对肝癌诊断的研究[J].检验医学与临床,2017,14(9):1260-1261,1265.[12]Wang ZD,Qu FY,Chen YY,et al.Involvement of microRNA-718, a new regulator of EGR3, in regulation of malignant phenotype of HCC cells[J].J Zhejiang Univ Sci B,2017,18(1):27-36.[13]Liu W,Hu J,Zhou K,et al.Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma[J].Onco Targets Ther,2017(10):3843-3851.[14]Jiao C,Jiao X,Zhu A,et al.Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma[J].Journal of Pediatric Surgery,2017,52(4):618-624.[15]Lou G,Song X,Yang F,et al.Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma[J].Journal of Hematology & Oncology,2015,8(1):122.[16]Zhang Z,Li X,Sun W,et al.Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis[J].Cancer Letters,2017(397):33-42.[17]Xiong L,Zhen S,Yu Q,et al.HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs[J].Oncology Letters,2017,14(2):2141-2146.[18]Chen G,Wang Z,Wang D,et al.LncRNADisease:a database for long-non-coding RNA-associated diseases[J].Nucleic Acids Res,2013,41(Database issue):D983-D986.[19]Conigliaro A,Costa V,Lo Dico A,et al.CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA[J].Molecular Cancer,2015,14(1):155.[20]Takahashi K,Yan IK,Wood J,et al.Involvement of Extracellular Vesicle Long Noncoding RNA (linc-VLDLR) in Tumor Cell Responses to Chemotherapy[J].Molecular Cancer Research,2014,12(10):1377-1387.[21]Kogure T,Yan IK,Lin WL,et al.Extracellular Vesicle-Mediated Transfer of a Novel Long Noncoding RNA TUC339: A Mechanism of Intercellular Signaling in Human Hepatocellular Cancer[J].Genes & Cancer,2013,4(7-8):261-272.[22]Ma J,Cai W,Zhang Y,et al.Innate Immune Cell-Derived Microparticles Facilitate Hepatocarcinoma Metastasis by Transferring Integrin alpha(M)beta(2) to Tumor Cells[J].The Journal of Immunology,2013,191(6):3453-3461.[23]Jaiswal R,Gong J,Sambasivam S,et al.Microparticle-associated nucleic acids mediate trait dominance in cancer[J].The FASEB Journal,2012,26(1):420-429.[24]Wei JX,Lv LH,Wan YL,et al.Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells[J].Hepatology,2015,61(4):1284-1294.
相似文献/References:
[1]修朋程,李 腾,李雅林,等.泰山山慈菇对小鼠肝癌的治疗作用及相关免疫机制研究[J].医学信息,2018,31(09):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
XIU Peng-cheng,LI Teng,LI Ya-lin,et al.Study on the Therapeutic Effect and Mechanism of Taishan Mountain Mushroom on Liver Cancer in Mice[J].Medical Information,2018,31(08):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
[2]崔康健,杜成友.肝动脉化疗栓塞联合射频消融治疗肝癌的研究进展[J].医学信息,2018,31(09):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
CUI Kang-jian,DU Cheng-you.Research Progress of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation for Liver Cancer[J].Medical Information,2018,31(08):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
[3]李在明,魏正强.外泌体在结直肠癌中的研究进展[J].医学信息,2019,32(03):42.[doi:10.3969/j.issn.1006-1959.2019.03.014]
LI Zai-ming,WEI Zheng-qiang.Research Progress of Exosomes in Colorectal Cancer[J].Medical Information,2019,32(08):42.[doi:10.3969/j.issn.1006-1959.2019.03.014]
[4]田 明,常伟平.UbcH10在肝癌中的表达及其与预后的关系[J].医学信息,2019,32(12):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
IAN Ming,CHANG Wei-ping.Expression of UbcH10 in Hepatocellular Carcinoma and Its Relationship with Prognosis[J].Medical Information,2019,32(08):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
[5]许 吉.基于知识图谱和专利地图的我国抗肝癌药物研发态势研究[J].医学信息,2018,31(21):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
XU Ji.Research and Development Situation of Anti-liver Cancer Drugs in China Based on Knowledge Map and Patent Map[J].Medical Information,2018,31(08):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
[6]兰福全,李秀云,卢 斌.四种肿瘤标志物对肝癌诊断的临床意义[J].医学信息,2018,31(21):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
LAN Fu-quan,LI Xiu-yun,LU Bin.The Clinical Significance of Four Tumor Markers in the Diagnosis of Liver Cancer[J].Medical Information,2018,31(08):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
[7]李 闯,叶劲松,刘 昕,等.ZBP-89与缺氧信号因子HIF-1α在肝癌细胞中的
相关性研究[J].医学信息,2019,32(15):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
LI Chuang,YE Jin-song,LIU Xin,et al.Correlation between ZBP-89 and Hypoxia Signaling Factor HIF-1α in Hepatoma Cells[J].Medical Information,2019,32(08):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
[8]赵瑶瑶,高 川,胡佳杰.循环miRNA监测肝细癌的研究[J].医学信息,2019,32(08):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
ZHAO Yao-yao,GAO Chuan,HU Jia-jie.Research on the Study of Circulating miRNA for Monitoring Hepatocellular Carcinoma[J].Medical Information,2019,32(08):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
[9]孙 逊.性化护理对肝癌患者CT引导下射频消融术后
负性情绪及生活质量的影响[J].医学信息,2019,32(17):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
SUN Xun.Effect of Humanized Nursing on Negative Emotion and Quality of Life after
CT-guided Radiofrequency Ablation in Patients with Liver Cancer[J].Medical Information,2019,32(08):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
[10]徐 蓓,魏霞丽,常艳琴.肝癌患者术后自我饮食管理体验的质性研究[J].医学信息,2019,32(20):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
XU Bei,WEI Xia-li,CHANG Yan-qin.Qualitative Study of Postoperative Self-Catering Management Experience in Patients with Liver Cancer[J].Medical Information,2019,32(08):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
[11]蒋佳红,李 游,邓知敏,等.外泌体在肝癌中的应用研究[J].医学信息,2020,33(24):28.[doi:10.3969/j.issn.1006-1959.2020.24.009]
JIANG Jia-hong,LI You,DENG Zhi-min,et al.Study on the Application of Exosomes in Liver Cancer[J].Medical Information,2020,33(08):28.[doi:10.3969/j.issn.1006-1959.2020.24.009]